Edition:
United States

Transition Therapeutics Inc (TTHI.OQ)

TTHI.OQ on NASDAQ Stock Exchange Global Market

1.48USD
25 Aug 2016
Change (% chg)

-- (--)
Prev Close
$1.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,550
52-wk High
$2.74
52-wk Low
$0.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.06 June 26 Aug 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.67 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 1 0.00 0.00 0.00 --
Year Ending Jun-16 3 0.00 0.00 0.00 11.86
Year Ending Jun-17 3 0.00 0.00 0.00 2.50
Earnings (per share)
Quarter Ending Mar-16 1 -0.06 -0.06 -0.06 --
Quarter Ending Jun-16 1 -0.06 -0.06 -0.06 --
Year Ending Jun-16 3 -0.36 -0.31 -0.45 -0.81
Year Ending Jun-17 3 -1.02 -0.38 -1.90 -1.42

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-15 0.00 0.00 0.00 0.00
Quarter Ending Mar-15 0.00 0.00 0.00 0.00
Quarter Ending Sep-14 0.00 0.00 0.00 0.00
Quarter Ending Jun-13 3.50 7.12 3.62 103.37
Quarter Ending Dec-11 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-15 -0.36 -0.38 0.02 -5.03
Quarter Ending Mar-15 -0.32 -0.13 0.19 -59.94
Quarter Ending Sep-14 -0.17 -0.45 0.27 -157.14
Quarter Ending Mar-14 -0.07 -0.16 0.09 -128.57
Quarter Ending Dec-13 -0.06 -0.04 0.02 -33.33

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 0.00 0.00 0.00 0.00 --
Year Ending Jun-16 0.00 0.00 0.00 0.00 11.86
Year Ending Jun-17 0.00 0.00 0.00 0.00 2.50
Earnings (per share)
Quarter Ending Mar-16 -0.06 -- -- -- --
Quarter Ending Jun-16 -0.06 -0.06 -0.06 -0.06 --
Year Ending Jun-16 -0.36 -0.36 -0.36 -0.33 -0.81
Year Ending Jun-17 -1.02 -1.02 -1.02 -1.90 -1.42

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 0
Year Ending Jun-16 0 0 0 0
Year Ending Jun-17 0 0 0 0
Earnings
Quarter Ending Mar-16 -- -- -- --
Quarter Ending Jun-16 0 0 0 0
Year Ending Jun-16 0 0 0 0
Year Ending Jun-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : GlobalData
$300.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.